Aterian Inc vs Enveric Biosciences Inc — how do they compare? Aterian Inc trades at $0.48 (market cap $5.32M), while Enveric Biosciences Inc trades at $1.56 (market cap $6.20M). The key difference: Enveric Biosciences Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| ATER | ENVB | |
|---|---|---|
Market Cap | $5.32M | $6.20M |
Sector | Consumer Cyclical | Health |
52-Week High | $1.39 | $17.40 |
52-Week Low | $0.36 | $1.27 |
Enterprise Value | $5.90M | $1.30M |
Signals from Pluang's Aura AI — not financial advice
Aterian (ATER) trades at $0.48, down 2.72% on the day, with a bearish technical signal. The company reported a net loss of -$18.98M in 2025, though it has beaten EPS estimates in recent quarters. Recent news highlights a pending asset sale that could return $0.85–$1.14 per share to stockholders, subject to a special meeting vote.
The outlook hinges on the asset sale approval, offering potential upside, but ongoing operational losses and negative cash flow pose significant risks. Analyst sentiment is split evenly between Buy and Hold, reflecting uncertainty around the company's restructuring and future profitability.
No Aura AI signal available yet.
Trailing returns across standard periods
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →